The post Top Altcoins to Invest in as Solana (SOL) Targets Institutional Dominance  appeared on BitcoinEthereumNews.com. Smart money is accumulating Solana (SOL) and Mutuum Finance (MUTM) as institutional interest reshapes the crypto market. Solana is advancing toward dominance in institutional adoption while Mutuum Finance is gaining traction with its presale progress and unique DeFi model.  Together, these projects are capturing attention from investors looking at what crypto to buy now, with Solana targeting $300 and MUTM offering discounted access in its current presale. This dual momentum is building fresh interest in both altcoins as 2025 unfolds. Solana Gains Institutional Momentum Solana is continuing to establish itself as an institutional favorite. Analysts are assigning a 91% chance for a U.S. Solana ETF approval in October 2025. If this approval proceeds, inflows of up to $5.5 billion could follow, pushing the token toward $335.  Consequently, institutional backing is aligning with Solana’s technical progress to create strong upward pressure on crypto prices today. Moreover, public companies have already committed over $1.7 billion into staking Solana. Firms like DeFi Development Corp and Upexi Inc have added hundreds of millions to their treasuries. Furthermore, partnerships with R3 and PayPal are extending Solana’s utility into tokenized real-world assets, creating new use cases beyond DeFi. Although Ethereum remains a strong competitor, Solana’s technical upgrades, scalability, and ETF push are helping it maintain investor confidence. If the $220 resistance breaks, crypto predictions place its price between $270 and $330, making Solana one of the top cryptocurrencies being accumulated by institutions. Mutuum Finance Presale Strength While Solana is targeting institutions, Mutuum Finance (MUTM) is standing out as the best cheap crypto to buy now. Currently in Phase 6 of its presale, MUTM is selling at $0.035, already 3.5 times higher than its opening phase at $0.01.  $15,220,000 has been raised since presale began and total holders have surpassed 15,880. The presale is accelerating, and once… The post Top Altcoins to Invest in as Solana (SOL) Targets Institutional Dominance  appeared on BitcoinEthereumNews.com. Smart money is accumulating Solana (SOL) and Mutuum Finance (MUTM) as institutional interest reshapes the crypto market. Solana is advancing toward dominance in institutional adoption while Mutuum Finance is gaining traction with its presale progress and unique DeFi model.  Together, these projects are capturing attention from investors looking at what crypto to buy now, with Solana targeting $300 and MUTM offering discounted access in its current presale. This dual momentum is building fresh interest in both altcoins as 2025 unfolds. Solana Gains Institutional Momentum Solana is continuing to establish itself as an institutional favorite. Analysts are assigning a 91% chance for a U.S. Solana ETF approval in October 2025. If this approval proceeds, inflows of up to $5.5 billion could follow, pushing the token toward $335.  Consequently, institutional backing is aligning with Solana’s technical progress to create strong upward pressure on crypto prices today. Moreover, public companies have already committed over $1.7 billion into staking Solana. Firms like DeFi Development Corp and Upexi Inc have added hundreds of millions to their treasuries. Furthermore, partnerships with R3 and PayPal are extending Solana’s utility into tokenized real-world assets, creating new use cases beyond DeFi. Although Ethereum remains a strong competitor, Solana’s technical upgrades, scalability, and ETF push are helping it maintain investor confidence. If the $220 resistance breaks, crypto predictions place its price between $270 and $330, making Solana one of the top cryptocurrencies being accumulated by institutions. Mutuum Finance Presale Strength While Solana is targeting institutions, Mutuum Finance (MUTM) is standing out as the best cheap crypto to buy now. Currently in Phase 6 of its presale, MUTM is selling at $0.035, already 3.5 times higher than its opening phase at $0.01.  $15,220,000 has been raised since presale began and total holders have surpassed 15,880. The presale is accelerating, and once…

Top Altcoins to Invest in as Solana (SOL) Targets Institutional Dominance

Smart money is accumulating Solana (SOL) and Mutuum Finance (MUTM) as institutional interest reshapes the crypto market. Solana is advancing toward dominance in institutional adoption while Mutuum Finance is gaining traction with its presale progress and unique DeFi model. 

Together, these projects are capturing attention from investors looking at what crypto to buy now, with Solana targeting $300 and MUTM offering discounted access in its current presale. This dual momentum is building fresh interest in both altcoins as 2025 unfolds.

Solana Gains Institutional Momentum

Solana is continuing to establish itself as an institutional favorite. Analysts are assigning a 91% chance for a U.S. Solana ETF approval in October 2025. If this approval proceeds, inflows of up to $5.5 billion could follow, pushing the token toward $335. 

Consequently, institutional backing is aligning with Solana’s technical progress to create strong upward pressure on crypto prices today.

Moreover, public companies have already committed over $1.7 billion into staking Solana. Firms like DeFi Development Corp and Upexi Inc have added hundreds of millions to their treasuries.

Furthermore, partnerships with R3 and PayPal are extending Solana’s utility into tokenized real-world assets, creating new use cases beyond DeFi.

Although Ethereum remains a strong competitor, Solana’s technical upgrades, scalability, and ETF push are helping it maintain investor confidence. If the $220 resistance breaks, crypto predictions place its price between $270 and $330, making Solana one of the top cryptocurrencies being accumulated by institutions.

Mutuum Finance Presale Strength

While Solana is targeting institutions, Mutuum Finance (MUTM) is standing out as the best cheap crypto to buy now. Currently in Phase 6 of its presale, MUTM is selling at $0.035, already 3.5 times higher than its opening phase at $0.01. 

$15,220,000 has been raised since presale began and total holders have surpassed 15,880. The presale is accelerating, and once Phase 6 is over, Phase 7 will increase the price by 14.3 percent to $0.04. The token will be released at a price of $0.06 which will provide existing buyers with an estimated profit of more than 300 percent when the trading commences.

Mutuum Finance is developing a hybrid peer-to-peer and peer-to-contract lending system. This architecture enables users to borrow and lend assets safely and remain efficient on Layer 2. 

Borrowers will have access to flexible credit and lenders will have stable yield on blue-chip crypto coins. In addition, Mutuum Finance has implemented a stablecoin system that is minted at the time of loan issuance and burned at the time of repayment, decreasing the risk of inflation and making it stable.

Also, security and trust is a good selling point. The project is already CertiK audited (score 95.00) and no vulnerabilities have been identified in the last 90 days. CertiK is partnering with a bug bounty program, which is rewarding up to $50,000 USDT in rewards based on the level of severity. 

Moreover, Mutuum Finance has introduced a dashboard with a leaderboard, in which the 50 largest holders will be rewarded in bonus tokens, which will provide incentives to hold long-term.

Community participation is also growing. Mutuum Finance is likewise in the process of running a giveaway of 100,000 dollars, divided among 10 winners. All winners will be awarded 10,000 dollars of MUTM with a minimum entry of 50 dollars presale. This project is enhancing participation as well as increasing the demand of the tokens.

Smart Money Is Acting Early

Solana is attracting institutions that want exposure to scalable infrastructure, while Mutuum Finance is appealing to investors searching for the best cheap crypto to buy now. 

Both projects are benefiting from clear growth drivers, yet Mutuum Finance stands out for its presale opportunity that is still open. As Phase 6 continues selling out fast, investors have a short window before prices increase in Phase 7.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://mutuum.com/ 

Linktree: https://linktr.ee/mutuumfinance 

Source: https://www.cryptopolitan.com/top-altcoins-to-invest-in-as-solana-sol-targets-institutional-dominance/

Market Opportunity
Solana Logo
Solana Price(SOL)
$141.8
$141.8$141.8
-1.18%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23